• Return to Headlines

Pacira Pharmaceu Has Returned 14.1% Since SmarTrend Recommendation (PCRX)

By Shiri Gupta

SmarTrend identified a Downtrend for Pacira Pharmaceu (NASDAQ:PCRX) on December 18th, 2018 at $44.44. In approximately 3 weeks, Pacira Pharmaceu has returned 14.10% as of today's recent price of $38.17.

In the past 52 weeks, Pacira Pharmaceu share prices have been bracketed by a low of $26.95 and a high of $55.00 and are now at $38.17, 42% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.3% while the 50-day MA has declined 1.4%.

Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company with focuses on the development, commercialization, and manufacturing of proprietary pharmaceutical products. The Company's products are used in hospitals and ambulatory surgery centers.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Pacira Pharmaceu.

Log in and add Pacira Pharmaceu (PCRX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights pacira pharmaceu

Ticker(s): PCRX